Further in vivo data showed that the Ovcar4 cell line-based tumor model is highly resistant to cisplatin/paclitaxel treatment even prior overexpression of BRD4 isoforms, which is in agreement with literature [52]. The gene discussed is BRD4; the disease is neoplasm.